Skip to content
Recall Observatory FDA recall evidence

Drug product

Diltiazem HCl Extended-release Capsules, USP, 120 mg, packaged in 80 Capsules (8 x 10) blister cards per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 51079-947-08.

D-1435-2014

July 03, 2014

Class III

Product summary

Firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Event
Event 68787
Status
Terminated
Classification
Class III
Quantity
1,184 cartons
Official record key
drug-enforcement:D-1435-2014

Official wording

Reason: Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.

Code information: Lot #: 3045659, 3048256, Exp 07/14

Distribution pattern: Nationwide, Puerto Rico, and Guam.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out-of-specification